0000914190-18-000365.txt : 20180830
0000914190-18-000365.hdr.sgml : 20180830
20180830161737
ACCESSION NUMBER: 0000914190-18-000365
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180828
FILED AS OF DATE: 20180830
DATE AS OF CHANGE: 20180830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Points Jeffrey S.
CENTRAL INDEX KEY: 0001731414
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52082
FILM NUMBER: 181047310
MAIL ADDRESS:
STREET 1: C/O CARDIOVASCULAR SYSTEMS, INC.
STREET 2: 1225 OLD HIGHWAY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardiovascular Systems Inc
CENTRAL INDEX KEY: 0001180145
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411698056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 1225 OLD HWY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
BUSINESS PHONE: 651-259-1600
MAIL ADDRESS:
STREET 1: 1225 OLD HWY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
FORMER COMPANY:
FORMER CONFORMED NAME: REPLIDYNE INC
DATE OF NAME CHANGE: 20020813
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-08-28
0001180145
Cardiovascular Systems Inc
CSII
0001731414
Points Jeffrey S.
1225 OLD HIGHWAY 8 NW
ST. PAUL
MN
55112
0
1
0
0
Chief Financial Officer
Common Stock
2018-08-28
4
A
0
4742
0
A
27971
D
Common Stock
2018-08-28
4
A
0
14225
0
A
42196
D
Restrictions lapse as to 1,581 shares on each of 8/28/19 and 8/28/20 and as to 1,580 shares on 8/28/21.
Subject to performance-based forfeiture based on the Company's three-year total shareholder return for fiscal years 2019, 2020 and 2021 versus the Company's peer group.
/s/ Amanda Lorentz as Attorney-in-Fact for Jeffrey S. Points pursuant to Power of Attorney previously filed.
2018-08-30